• 无工作经验
  • 本科
  • 招若干人
  • 11-09 发布
  • 五险一金
  • 年终奖金
  • 绩效奖金
  • 餐饮补贴
  • 通讯补贴

职位描述

职位描述: Responsibility:1Work closely with clients to ensure the high quality of the projects2Relationship management and liaison with existing clients and the fostering of new client relationships through project work and personal contacts3Development of economic evaluation plans, health economic models and statistical analysis4Coordination and timely delivery of high quality projects including economic models, multi-country adaptations and health economic publications5Collecting medical data based on project need.Qualifications:1Bachelor’s Degree or above in Medicine or Pharmaceuticals, Economics, Business or other related field is required.2A high-level understanding of health economic principles and analysis32-3 years experience in Healthcare Economics, Data Analysis, or Marketing survey in pharmaceuticals.4A proven track record of project delivery and experience in leading health economic projects is preferred.5Demonstrable ability to cope with competing demands6Exceptional communication skills, especially in respect to communicating health economic principles to non-economists7Excellent oral and written English communication skills required. Oral and written skills in at least one additional language.8A sound understanding of medical statistics such as meta-analysis, multiple imputation and survival analysis would be desirable 职能类别: 其他 关键字: 周末双休

联系方式

上海市徐汇区肇嘉浜路1065号飞雕国际大厦16楼1605E室

公司信息

上海盛特尼医药科技有限公司是一家主要从事卫生经济和医疗咨询服务的公司,由一群顶尖的行业专家包括卫生经济学家、结果研究专家、临床医师、政策法规和安全/风险管理专家等创立。 上海盛特尼医药科技咨询公司为全球制药和医疗器械企业的产品提供整个生命周期的管理和咨询,其中包括:卫生经济、卫生技术评估,法规事务,市场切入,临床试验、数据管理及统计分析和风险管理解决方案。 上海盛特尼医药科技的专业团队熟知亚洲、美国、欧洲以及其他新兴市场的医疗卫生体系,同时,我们与世界其他卫生经济咨询公司的密切合作也使得公司不断拓展全球业务。 我们的服务覆盖产品生命周期的每一个阶段,包括: 1. 对药品上市前的临床和结果评价 2. 注册及国际多中心临床试验申请的递交 3. I-IV 四期临床试验的管理 4. II/III期临床试验中病例报告结果以及经济学研究的设计,执行,分析以及报告 5. 建立卫生经济模型 6. 为定价决策提供支持 7. 为满足市场切入的要求制定相关策略 8. 根据国家要求,准备卫生技术评估及卫生结果价值材料( health outcomes value dossiers ); 9. 上市后市场切入策略的制定以及交流工具开发 10. 制定政策法规和风险管理战略计划 除了核心科学团队,我们有一个由世界知名的行业专家组成的国际顾问委员会,他们的专业涵盖卫生经济,生物统计,政策研究,市场切入/ 卫生技术评估等。 在需要的时候,他们可随时提供帮助支持。 对于每一个项目,无论它涉及卫生经济,系统综述,卫生技术评估,法规事务还是市场切入,“知识、创新、智慧”都是盛特尼不变的追求。 上海盛特尼医药科技主要业务包括: 卫生技术评估; 结果研究; 市场切入; 定价; 报销研究; 临床试验、数据管理及统计分析; 法规事务; 安全与风险评估 Shanghai Centennial Scientific Ltd. is a premium health economic and health care consulting company in China established by top specialists including health economicists, outcomes researchers, statisticians, clinicians, regulatory and safety/risk management professionals. Shanghai Centennial Scientific offers professional consulting services throughout the product lifecycle. We delivers health economic, HTA, regulatory affairs, market access,clinical trial and data management, and risk management solutions to global and local pharmaceutical/medical device companies. Shanghai Centennial Scientific’s highly specialized team consists of top experts in health economists, market access, regulatory, medical writing, clinical and safety data management, as well as database and multimedia experts. Our scientific team has a through understanding of Asia, US, European and other emerging market health care systems. The company is also closely connected with other global health economic companies to facilitate our global presence. In addition to our core scientific team, we have an affiliated international scientific board comprised with a group of globally recognized experts in the area of health economics, biostatistics, policy research, market access/HTA, and graphics designing to support us on an as-needed basis Shanghai Centennial Scientific bring knowledge, creativity and intellect to every project we undertake whether it is health economics, systematic review, HTA, regulatory affairs, safety accessment, or market access. Shanghai Centennial Scientific’s key deliverables include: 1.Health technology Assessment 2.Outcomes Researches 3.Market Access 4.Pricing 5.Reimbursement Research 6.Clinical trial and data management 7.Regulatory affairs 8.Safety and risk management Our services have evolved over time to meet the increasing need for health economic, evidence based solutions, clinical data management, regulatory and risk management; our vast experience across a wide range of disease areas is second to none. We provide services at every stage of the product lifecycle including: 1.Pre-launch evaluations of disease burden and outcome evidence 2.Registration or global trial submission 3.Phase I-IV clinical trial management 4.Phase II/III patient reported outcomes and economic study design, conduct, analysis, and report 5.Development of comprehensive health economic models 6.Input into pricing decisions and develop strategy to meet market access requirements 7.Preparation of HTA and health outcomes value dossiers according to country requirement 8.Development of post-launch access strategy and communication tools 9.Develop regulatory and risk management strategic plan

猎才二维码